ACTA1 and colorectal carcinoma: Interestingly, we found that inhibition of TGF-β reduced not only the expression of GLUT3 but also the expression of EMT-related markers such as α-SMA, ZEB1 and PAI-1 as well as the potential invasive ability of genetically GLUT3-overexpressed CRC cells.